ethylisopropylamiloride has been researched along with Cancer of Stomach in 1 studies
ethylisopropylamiloride: structure in first source
ethylisopropylamiloride : A member of the class of pyrazines that is amiloride in which the amino substitutent of the pyrazine ring that is adjacent to the chloro substituent has been substituted by an ethyl group and by an isopropyl group.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hosogi, S | 1 |
| Miyazaki, H | 1 |
| Nakajima, K | 1 |
| Ashihara, E | 1 |
| Niisato, N | 1 |
| Kusuzaki, K | 1 |
| Marunaka, Y | 1 |
1 other study available for ethylisopropylamiloride and Cancer of Stomach
| Article | Year |
|---|---|
An inhibitor of Na(+)/H(+) exchanger (NHE), ethyl-isopropyl amiloride (EIPA), diminishes proliferation of MKN28 human gastric cancer cells by decreasing the cytosolic Cl(-) concentration via DIDS-sensitive pathways.
Topics: 4,4'-Diisothiocyanostilbene-2,2'-Disulfonic Acid; Amiloride; Antineoplastic Agents; Cell Proliferati | 2012 |